Private company

Shockwave Medical, Inc.

In its 2024 annual report the company says: “We are a medical device company focused on developing and commercializing novel technologies that transform the care of patients with cardiovascular disease. Our IVL system, which leverages our IVL technology, is a minimally invasive, easy-to-use, and safe way to improve outcomes for patients with calcified cardiovascular disease.”5 It is headquartered in Santa Clara, United States.2

Last updated Oct 20, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus2
  • HeadquartersSanta Clara, United States2
  • Incorporated inDE3
  • Business address5403 Betsy Ross Drive, Santa Clara, Ca 950543
  • Filer categoryLarge accelerated filer3
  • Legal formCorporation2
  • LEI549300LDXO56IC5Y15382
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 46575532

See how the biggest companies compare on our leaderboards

We are a medical device company focused on developing and commercializing novel technologies that transform the care of patients with cardiovascular disease. We aim to establish a new standard of care for the treatment of calcified cardiovascular disease (“atherosclerosis”) through our differentiated and proprietary local delivery of sonic pressure waves, which we refer to as intravascular lithotripsy (“IVL”). Our IVL system (our “IVL System”), which leverages our IVL technology (our “IVL Technology”), is a minimally invasive, easy-to-use, and safe way to improve outcomes for patients with calcified cardiovascular disease. Additionally, we aim to transform the standard of care for patients suffering from refractory angina with our coronary sinus reducer (the “Reducer”) technology, an innovative technology that creates a permanent, controlled narrowing of the coronary sinus.5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

86.9%Gross margin6
21.8%Operating margin6
20.2%Net margin6
49.1%Revenue growth, 20236
22.0%Return on equity6
$165.5MFree cash flow6

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue13¢$95.4M
  • Research and development20¢$145.6M
  • Other costs42¢$308.0M
  • Interest1¢$6.9M
  • Income tax4¢$27.0M
  • Profit20¢$147.3M

Out of $730.2M in revenue.6

Where each dollar of operating cash went, fiscal 2023

  • Capital spending16¢$30.6M
  • Kept or used elsewhere84¢$165.5M

Out of $196.1M of cash from operations.6

Financial statements

Revenue789106$730.2M in 2023+42380% since 2017
0$200.0M$400.0M$600.0M$800.0M2017: $1.7M$1.7M20172018: $12.3M$12.3M2018+613%2019: $42.9M$42.9M2019+250%2020: $67.8M$67.8M2020+58%2021: $237.1M$237.1M2021+250%2022: $489.7M$489.7M2022+107%2023: $730.2M$730.2M2023+49%
Gross profit89106$634.8M in 2023+12564% since 2018
0$200.0M$400.0M$600.0M$800.0M2018: $5.0M$5.0M20182019: $25.8M$25.8M2019+414%2020: $46.8M$46.8M2020+82%2021: $195.7M$195.7M2021+318%2022: $424.7M$424.7M2022+117%2023: $634.8M$634.8M2023+49%
Operating income789106$159.1M in 2023
-$100.0M0$100.0M$200.0M2017: -$30.9M-$30.9M20172018: -$41.2M-$41.2M2018+33%2019: -$51.8M-$51.8M2019+26%2020: -$65.7M-$65.7M2020+27%2021: -$871.0K-$871.0K2021−99%2022: $124.1M$124.1M20222023: $159.1M$159.1M2023+28%
Net income789106$147.3M in 2023
-$100.0M0$100.0M$200.0M$300.0M2017: -$30.6M-$30.6M20172018: -$41.1M-$41.1M2018+34%2019: -$51.1M-$51.1M2019+24%2020: -$65.7M-$65.7M2020+29%2021: -$9.1M-$9.1M2021−86%2022: $216.0M$216.0M20222023: $147.3M$147.3M2023−32%
Fiscal year2017201820192020202120222023
Revenue$1.7M7$12.3M8$42.9M9$67.8M10$237.1M6$489.7M6$730.2M6
Cost of revenue$2.8M7$7.2M8$17.2M9$21.0M10$41.4M6$65.0M6$95.4M6
Gross profit$5.0M8$25.8M9$46.8M10$195.7M6$424.7M6$634.8M6
Research and development$18.0M7$22.7M8$32.9M9$36.9M10$50.5M6$81.7M6$145.6M6
Operating expenses$196.6M6$300.6M6$475.7M6
Operating income-$30.9M7-$41.2M8-$51.8M9-$65.7M10-$871.0K6$124.1M6$159.1M6
Interest$58.0K7$401.0K8$944.0K9$1.2M10$1.1M6$1.9M6$6.9M6
Income before tax-$8.8M6$120.8M6$174.3M6
Income tax$26.0K7$38.0K8$62.0K9$80.0K10$301.0K6-$95.2M6$27.0M6
Net income-$30.6M7-$41.1M8-$51.1M9-$65.7M10-$9.1M6$216.0M6$147.3M6
Earnings per share-$1.9910-$0.266$6.026$4.016
Earnings per share (diluted)-$1.9910-$0.266$5.706$3.856
Shares (weighted, basic)35.1M shares635.9M shares636.7M shares6
Shares (weighted, diluted)35.1M shares637.9M shares638.2M shares6

Compare Shockwave Medical, Inc. with another company

Corporate structure

Shockwave Medical, Inc. is part of a group headed by Johnson & Johnson. 458 entities, 73 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Shockwave Medical, Inc.

  • FMR LLC Filed SC 13G/A on Shockwave Medical, Inc., latest Jul 10, 2024 (4 filings since Jan 10, 2022)
  • VANGUARD GROUP INC Filed SC 13G/A on Shockwave Medical, Inc., latest Feb 13, 2024 (3 filings since Feb 10, 2022)
  • Wellington Management Company Filed SC 13G on Shockwave Medical, Inc., latest Feb 8, 2024
  • PRICE T ROWE ASSOCIATES INC /MD/ Filed SC 13G/A on Shockwave Medical, Inc., latest Feb 14, 2023 (2 filings since Feb 14, 2022)
  • GILDER GAGNON HOWE & CO LLC Filed SC 13G/A on Shockwave Medical, Inc., latest Feb 14, 2022
  • JPMorgan Chase Filed SC 13G/A on Shockwave Medical, Inc., latest Nov 9, 2021

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Shockwave Medical, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$86.0M6 Dec 31, 2023$58.3M6 Dec 31, 2022+47.4%
Accumulated depreciation$17.1M6 Dec 31, 2023$10.2M6 Dec 31, 2022+67.8%
Property and equipment, net$68.9M6 Dec 31, 2023$48.2M6 Dec 31, 2022+43.1%
Operating-lease assets (leased space)$29.7M6 Dec 31, 2023$32.4M6 Dec 31, 2022−8.2%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$328.4M6 Dec 31, 2023$156.6M6 Dec 31, 2022+109.7%
Marketable securities, current$662.1M6 Dec 31, 2023$147.9M6 Dec 31, 2022+347.7%
Stakes in other companies (equity method)$1.6M6 Dec 31, 2023$3.5M6 Dec 31, 2022−53.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$39.6M6 Dec 31, 2023$06 Dec 31, 2022
Intangible assets, net (excluding goodwill)$92.9M6 Dec 31, 2023$06 Dec 31, 2022
Accumulated amortization$2.6M6 Dec 31, 2023
Finite-lived intangibles, net$61.5M6 Dec 31, 2023

Inventory

ItemLatestA year beforeChange
Inventory, total$107.6M6 Dec 31, 2023$75.1M6 Dec 31, 2022+43.2%
Raw materials$25.7M6 Dec 31, 2023$18.5M6 Dec 31, 2022+39.1%
Work in process$16.5M6 Dec 31, 2023$7.7M6 Dec 31, 2022+115.2%
Finished goods$65.4M6 Dec 31, 2023$49.0M6 Dec 31, 2022+33.5%

Leadership

Who has led Shockwave Medical, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Douglas Evan Godshall2019–2024

President

  1. Douglas Evan Godshall2019–2024
  2. Isaac Zacharias2022–2024

Chief financial officer

  1. Renee Gaeta2024
20202025
Board members and other officers (11)

Subsidiaries and ownership

Parent company (GLEIF)

Subsidiaries (Exhibit 21)

  • Genesis Shockwave Private Limited Singapore4
  • Neovasc GmbH Germany4
  • Neovasc Inc. Canada4
  • Neovasc Tiara Inc. Canada4
  • SWAV CR Sociedad de Responsabilidad Limitada Costa Rica4
  • SWAV Medical Spain, S.L. Spain4
  • Shockwave Medical France SàRL France4
  • Shockwave Medical GmbH Germany4
  • Shockwave Medical India Private Limited India4
  • Shockwave Medical Ireland Limited Ireland4
  • Shockwave Medical Italy S.R.L. Italy4
  • Shockwave Medical Japan KK Japan4
  • Shockwave Medical Portugal, Unipessoal Lda. Portugal4
  • Shockwave Medical UK Limited United Kingdom4

Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record. The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Timeline

  1. May 31, 2024Parent Directly consolidated by Johnson & Johnson2
  2. May 31, 20248-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale27
  3. May 30, 20248-K Shareholder vote28
  4. May 21, 20248-K Other events29
  5. May 6, 20248-K Results of operations30
  6. Apr 9, 20248-K Executive or director change31
  7. Apr 5, 20248-K Entered a material agreement; Regulation FD disclosure32
  8. Mar 1, 20248-K Change of auditor33
  9. Feb 15, 20248-K Results of operations34
  10. Jan 29, 20248-K Executive or director change; Regulation FD disclosure35
  11. Nov 6, 20238-K Results of operations36
  12. Sep 11, 20238-K Executive or director change37
  13. Aug 15, 20238-K Entered a material agreement; New debt or obligation; Unregistered sale of shares38
  14. Mar 6, 2019New chief executive Douglas Evan Godshall becomes CEO14
  15. Jun 17, 2009Founded Shockwave Medical, Inc. is founded2

Calendar

When it reported results

  1. May 6, 2024Reported quarterly or annual results30
  2. Feb 15, 2024Reported quarterly or annual results34
  3. Nov 6, 2023Reported quarterly or annual results36
  4. Aug 7, 2023Reported quarterly or annual results39
  5. May 8, 2023Reported quarterly or annual results40
  6. Feb 16, 2023Reported quarterly or annual results41
  7. Jan 17, 2023Reported quarterly or annual results42
  8. Nov 7, 2022Reported quarterly or annual results43

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

356 filings to the SEC since October 2021: 4 annual reports, 8 quarterly reports, 32 major events, 228 insider forms, 12 large holders, 72 other. The latest 20:

  1. Jul 10, 2024SC 13G/A EDGAR
  2. Jun 10, 202415-12G EDGAR
  3. May 31, 20244 EDGAR
  4. May 31, 20244 EDGAR
  5. May 31, 20244 EDGAR
  6. May 31, 20244 EDGAR
  7. May 31, 20244 EDGAR
  8. May 31, 20244 EDGAR
  9. May 31, 20244 EDGAR
  10. May 31, 20244 EDGAR
  11. May 31, 20244 EDGAR
  12. May 31, 20244 EDGAR
  13. May 31, 20244 EDGAR
  14. May 31, 20244 EDGAR
  15. May 31, 2024S-8 POS EDGAR
  16. May 31, 2024S-8 POS EDGAR
  17. May 31, 2024S-8 POS EDGAR
  18. May 31, 2024S-8 POS EDGAR
  19. May 31, 2024S-8 POS EDGAR
  20. May 31, 2024S-8 POS EDGAR

The 356 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

132 open-market trades by officers, directors and large owners since October 2021: 0 buys and 132 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 26, 2024FRANCIS LAURADirectorSale1,500$300.00$450.0KForm 4
Mar 26, 2024Zacharias IsaacPresident, CCOSale4,000$287.67$1.2MForm 4
Mar 6, 2024WATKINS FRANK TDirectorSale2,000$253.65$507.3KForm 4
Mar 6, 2024Phung TrinhSVP, FinanceSale21$253.14$5.3KForm 4
Feb 26, 2024Zacharias IsaacPresident, CCOSale4,000$260.36$1.0MForm 4
Feb 22, 2024Phung TrinhSVP, FinanceSale599$259.24$155.3KForm 4
Feb 21, 2024MOLL FREDERIC HDirectorSale60,000$257.39$15.4MForm 4
Feb 16, 2024FRANCIS LAURADirectorSale1,000$250.00$250.0KForm 4
Feb 15, 2024Godshall Douglas EvanPresident & CEOSale10,000$231.56$2.3MForm 4
Feb 6, 2024Phung TrinhSVP, FinanceSale1,287$232.18$298.8KForm 4
Feb 6, 2024WATKINS FRANK TDirectorSale2,000$231.76$463.5KForm 4
Feb 5, 2024PUCKETT DANChief Financial OfficerSale3,229$231.15$746.4KForm 4
Feb 1, 2024PUCKETT DANChief Financial OfficerSale3,406$229.76$782.6KForm 4
Jan 26, 2024Zacharias IsaacPresident, CCOSale4,000$224.69$898.8KForm 4
Jan 16, 2024Godshall Douglas EvanPresident & CEOSale10,000$217.59$2.2MForm 4
Jan 8, 2024WATKINS FRANK TDirectorSale2,000$198.99$398.0KForm 4
Jan 5, 2024Godshall Douglas EvanPresident & CEOSale10,000$200.05$2.0MForm 4
Dec 26, 2023Zacharias IsaacPresident, CCOSale4,000$192.50$770.0KForm 4
Dec 15, 2023Godshall Douglas EvanPresident & CEOSale5,000$187.79$939.0KForm 4
Dec 8, 2023PUCKETT DANChief Financial OfficerSale200$173.88$34.8KForm 4

All 132 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Shockwave Medical, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARShockwave Medical, Inc.1
  • CIK0001642545
  • Employer ID (EIN)27-04941011
  • Filer statusLarge accelerated filer1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address5403 Betsy Ross Drive, Santa Clara, CA 950541
  • Phone(510) 279-42621
  • Shares outstanding37,543,542 as of May 1, 202413
  • Public float$7.7B as of Jun 30, 202350
  • On EDGAR sinceMay 22, 20151
  • Filings624 in all: 4 (372), 8-K (53), 144 (47), SC 13G/A (22), 3 (17), 10-Q (16), SC 13G (9), 4/A (8)1
    All 41 form types

    DEFA14A (8), S-8 (6), S-8 POS (6), 10-K (5), CORRESP (5), D (4), DEF 14A (4), 5 (3), SC 13D/A (3), SD (3), UPLOAD (3), 424B4 (2), 424B5 (2), DRS (2), EFFECT (2), S-1 (2), S-1/A (2), S-1MEF (2), SC 13D (2), 10-K/A (1), 15-12G (1), 25-NSE (1), 8-A12B (1), 8-K/A (1), ARS (1), CERT (1), D/A (1), DEFM14A (1), DFAN14A (1), FWP (1), POSASR (1), PREM14A (1), S-3ASR (1)

  • Latest filingsAnnual report (10-K) Feb 26, 2024
    Quarterly report (10-Q) May 6, 2024
    Proxy statement (DEF 14A) Apr 21, 2023
    Latest 8-K (8-K) May 31, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
    SEC EDGAROther events
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50